Identify Ferret and Hamster Immunoreagents for Project Planning

Funding News Edition: December 01, 2021
See more articles in this edition

NIAID seeks feedback from the research community to inform a time-sensitive Request for Information (RFI): Highest Priority Needs for Ferret and Hamster Immunoreagents. The RFI will help NIAID assess high-priority needs for immunoreagents (specifically, monoclonal antibodies and aptamers) against ferret and hamster antigens.

Despite the decades-long use of ferrets and Syrian hamsters to study the pathogenesis of a variety of human pathogens, a lack of immunoreagents to assess ferret and hamster immune responses poses a major barrier to studying pathogenesis and host immunity.

To broaden the use of these animal models, NIAID is currently funding several contracts to develop and validate monoclonal antibody and aptamer reagents against ferret and hamster immunoproteins.

Information Requested

NIAID seeks input from stakeholders throughout the scientific research community regarding the following topics:

  • Describe your experience using ferrets and/or hamsters for research
  • Describe your thoughts on “high-priority" molecular targets on ferret or hamster cells for which immunoreagents are critically needed
  • Provide additional “moderate-” or “lower-priority" (molecular) targets on ferret or hamster cells for which immunoreagents would aid in research
  • Provide thoughts on which molecular targets should be considered the highest priorities

How To Submit a Response

Email responses and questions to Dr. Chelsea Lane at by January 4, 2022. Responses to this RFI are voluntary. Do not include any proprietary, classified, or confidential information in your responses.

You might also reference NIAID’s instructions and advice for Research Using Vertebrate Animals.

Contact Us

Email us at for help navigating NIAID’s grant and contract policies and procedures.

Content last reviewed on